We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+7.02%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$4.22B
AUM Growth
-$873M
Cap. Flow
-$1.18B
Cap. Flow %
-28.02%
Top 10 Hldgs %
31.05%
Holding
110
New
22
Increased
26
Reduced
27
Closed
30

Top Buys

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$94.6M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$79.4M
3
ZBH icon
Zimmer Biomet
ZBH
+$78.6M
4
DVA icon
DaVita
DVA
+$74.5M
5
HOLX
Hologic
HOLX
+$69M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$103M
2
CNC icon
Centene
CNC
+$85.6M
3
AGN.PRA
Allergan plc
AGN.PRA
+$79.2M
4
JD icon
JD.com
JD
+$78.6M
5
ELV icon
Elevance Health
ELV
+$77.6M

Sector Composition

Rank Sector Weight
1 Healthcare 48.28%
2 Technology 12.7%
3 Communication Services 3.9%
4 Financials 3.09%
5 Consumer Discretionary 2.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BABA icon
26
Alibaba
BABA
$269B
$62.1M 1.47%
360,420
-3,921
-1% -$703K
CI icon
27
Cigna
CI
$76.6B
$60.3M 1.43%
297,035
-130,339
-30% -$25.9M
ELV icon
28
Elevance Health
ELV
$81.9B
$60.3M 1.43%
267,805
-364,516
-58% -$77.6M
BOX icon
29
Box
BOX
$4.02B
$60.1M 1.43%
2,847,325
-48,889
-2% -$1.03M
ESPR
30
DELISTED
Esperion Therapeutics
ESPR
$57.3M 1.36%
870,102
+321,420
+59% +$17.3M
CME icon
31
CME Group
CME
$92.2B
$57.3M 1.36%
+392,106
New +$55.8M
MYOK
32
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$54.5M 1.29%
1,293,360
-323,594
-20% -$12.5M
MMSI icon
33
Merit Medical Systems
MMSI
$4.43B
$51.8M 1.23%
1,199,081
+491,641
+69% +$20.6M
PYPL icon
34
PayPal
PYPL
$49.5B
$50.9M 1.21%
691,622
-59,453
-8% -$4.3M
MDCO
35
DELISTED
Medicines Co
MDCO
$50.4M 1.2%
1,845,052
+344,049
+23% +$10.6M
ZAYO
36
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$48.5M 1.15%
1,318,879
-698,918
-35% -$24.7M
UHS icon
37
Universal Health Services
UHS
$9.43B
$46.9M 1.11%
+413,671
New +$44.2M
ZEN
38
DELISTED
ZENDESK INC
ZEN
$45.2M 1.07%
1,336,763
+354,931
+36% +$11.6M
GOOGL icon
39
Alphabet (Google) Class A
GOOGL
$3.91T
$45M 1.07%
854,380
-881,300
-51% -$45.5M
DXC icon
40
DXC Technology
DXC
$1.63B
$44.3M 1.05%
539,926
-1,498
-0.3% -$121K
ATVI
41
DELISTED
Activision Blizzard
ATVI
$44.1M 1.05%
696,151
-411,753
-37% -$26M
ANAB icon
42
AnaptysBio
ANAB
$1.6B
$42.9M 1.02%
+425,896
New +$31.4M
HRC
43
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$40.2M 0.95%
477,370
+172,632
+57% +$14M
ELGX
44
DELISTED
Endologix Inc
ELGX
$40.2M 0.95%
750,991
+85,093
+13% +$4.49M
ICLR icon
45
Icon
ICLR
$12.8B
$37.1M 0.88%
330,979
+47,784
+17% +$5.51M
MNK
46
PUT
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$37M 0.88%
+1,638,100
New +$43.9M
AMZN icon
47
Amazon
AMZN
$2.5T
$36.2M 0.86%
619,320
-1,267,320
-67% -$69.7M
NFLX icon
48
Netflix
NFLX
$292B
$28.2M 0.67%
1,471,620
-1,237,670
-46% -$23.8M
NVDA icon
49
NVIDIA
NVDA
$5.01T
$28M 0.66%
5,781,320
+803,960
+16% +$3.99M
SNNA
50
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$28M 0.66%
1,628,142
+47,732
+3% +$1.01M

Similar funds

PFM Health Sciences's Q4 2017 Portfolio in Review

As of Q4 2017, PFM Health Sciences held 110 positions worth $4.22B, down 17% from $5.09B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

PFM Health Sciences withdrew a net $1.18B in Q4 2017, closing 30 positions and reducing 27 holdings. Its most notable exit was Centene, an estimated $85.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 33% a quarter earlier, followed by Technology and Communication Services.

Against the trend, PFM Health Sciences opened a new position in Baidu worth $90.7M.

  • PFM Health Sciences's largest Q4 2017 buy was Baidu: 387,046 shares worth $90.7M.
  • PFM Health Sciences added most to Puma Biotechnology in Q4 2017, an estimated $50.6M increase.
  • PFM Health Sciences's biggest Q4 2017 reduction was Meta Platforms (Facebook), cutting an estimated $103M.
  • PFM Health Sciences fully exited Centene in Q4 2017, selling an estimated $85.6M.
  • PFM Health Sciences's ten largest holdings make up 31% of its $4.22B portfolio in Q4 2017.
  • PFM Health Sciences opened 22 new positions and closed 30 in Q4 2017.
  • PFM Health Sciences's portfolio value fell 17% quarter-over-quarter to $4.22B.

Based on PFM Health Sciences's 13F filing for Q4 2017, filed 14 Feb 2018.